Skip to main content
. 2013 Dec 12;16(2):274–279. doi: 10.1093/neuonc/not203

Fig. 1.

Fig. 1.

(A) Kaplan–Meier estimates of PFS in 41 patients receiving the HSPPC-96 vaccine for recurrent GBM. Vertical lines indicate the timepoints at which patients were censored. (B) Kaplan–Meier estimates of OS in 41 patients receiving the HSPPC-96 vaccine for recurrent GBM. Vertical lines indicate the timepoints at which patients were censored.